Sysmex Corp. will enter the cytogenetics market and expand its next-generation sequencing development capacity by acquiring Oxford Gene Technology Ltd. for an undisclosed sum, the companies announced on May 31.
The terms of the deal are not disclosed, but Kobe, Japan-based Sysmex says it will convert UK-based OGT into a wholly owned subsidiary to expand its product portfolio and reinforce its technology base in the life sciences
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?